Global Licensing Agreement
Advised Brickell Biotech
on the foregoing transaction
Series C Financing
Series A Financing
Advised R3 Vascular
on the foregoing transaction
Equity investment in Scioto Biosciences’ Series B and Strategic Collaboration with Scioto Biosciences
Advised Genome & Company
on the foregoing transaction
Series B Financing
Advised Adicet Bio
on the foregoing transaction
Series A Financing
Advised bioClarity
on the foregoing transaction
Series B Financing
Advised Oncologie
on the foregoing transaction
Strategic Collaboration & Global Licensing Agreement
Advised BridgeBio Therapeutics
on the foregoing transaction
Strategic Advice in Acquisition of Rezolute
Advised Handok/Genexine
on the foregoing transaction
Equity Financing
Advised MediBeacon
on the foregoing transaction
Series F Private Placement
Advised Atox Bio
on the foregoing transaction
Series B Financing
Advised Eloxx
on the foregoing transaction
At RMG, we strive to provide best-in-class services to our clients on their most complex strategic needs over the entire lifecycles of their businesses. With offices in New York and in Israel, our reach extends to Asia, Europe and the Americas, through our extensive network of relationships in the Life Sciences industry.
Corporate Venture Capital Management, Business Development, Project Assessment & Due Diligence Support, IPO Advice, Valuations & Fairness Opinions
READ MOREMergers and Acquisitions, Licensing, Distribution and Commercial Agreements, Divestitures and Spin-Outs
READ MORE
Corporate Strategy, Research & Development, Portfolio & Pipeline Strategy
READ MORE
Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and corporate finance support, based upon our comprehensive industry experience.
READ MORE